Sign In
Buy INCY
$97.98
+5.74 (+6.22%)
At Close: Jun 03, 2026
Incyte Ranked Second Among Science Magazine's 2020 Top Biopharma Employers
09:00am, Friday, 30'th Oct 2020
WILMINGTON, Del.--(BUSINESS WIRE)---- $INCY--Incyte Ranked Second Among Science Magazine's 2020 Top Biopharma Employers
INDIANAPOLIS, Oct. 30, 2020 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) and Incyte (NASDAQ: INCY) announced today new data for baricitinib (marketed as OLUMIANT®) will be presented at the annua
IBM Retirement Fund Boosts Stock Position in Incyte Co. (NASDAQ:INCY)
06:44am, Tuesday, 20'th Oct 2020
IBM Retirement Fund raised its position in shares of Incyte Co. (NASDAQ:INCY) by 39.1% in the 3rd quarter, according to the company in its most recent disclosure with the SEC. The fund owned 5,918 sha
Incyte to Report Third Quarter Financial Results
12:00am, Tuesday, 20'th Oct 2020
Incyte (Nasdaq:INCY) announced today that it has scheduled its third quarter financial results conference call and webcast for 8:00 a.m. ET on Thursda
Agios: A Look At TIBSOVO In CC Patients (NASDAQ:AGIO)
02:37pm, Monday, 19'th Oct 2020
This is the second time in 6 months that we are buying AGIOS. Last time was in April when the stock traded at $30ish; it went up to $56ish.
Sanders Morris Harris LLC Makes New $487,000 Investment in Incyte Co. (NASDAQ:INCY)
07:10am, Monday, 19'th Oct 2020
Sanders Morris Harris LLC acquired a new position in shares of Incyte Co. (NASDAQ:INCY) during the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exch
Assenagon Asset Management S.A. Has $798,000 Holdings in Incyte Co. (NASDAQ:INCY)
04:24am, Sunday, 18'th Oct 2020
Assenagon Asset Management S.A. lifted its holdings in shares of Incyte Co. (NASDAQ:INCY) by 69.7% during the third quarter, according to the company in its most recent Form 13F filing with the SEC. T
2,650 Shares in Incyte Co. (NASDAQ:INCY) Purchased by Carnegie Capital Asset Management LLC
08:56am, Friday, 16'th Oct 2020
Carnegie Capital Asset Management LLC bought a new position in shares of Incyte Co. (NASDAQ:INCY) in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchang
Redpoint Investment Management Pty Ltd Sells 377 Shares of Incyte Co. (NASDAQ:INCY)
08:10am, Wednesday, 14'th Oct 2020
Redpoint Investment Management Pty Ltd lessened its holdings in Incyte Co. (NASDAQ:INCY) by 9.1% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission
Week In Review: $1.5 Billion Total In Week's China Deals
07:32pm, Sunday, 11'th Oct 2020
10x Genomics acquired ReadCoor, a Boston developer of In Situ technologies, for $350 million. Corvus Pharma formed a China subsidiary, Angel Pharma, to develop its three clinical-stage assets and one
Bronchiolitis Obliterans Syndrome Market Clinical Analysis 2020 Incyte Corporation, Breath Therapeutics Inc., Genentech, Inc.
11:27am, Friday, 09'th Oct 2020
Oct 09, 2020 (Market Insight Reports) --
The Bronchiolitis Obliterans Syndrome Market 2020 report is a comprehensive, professional, and in-depth research of...
Baricitinib has Significant Effect on Recovery Time, Most Impactful in COVID-19 Patients Requiring Oxygen
03:39pm, Thursday, 08'th Oct 2020
INDIANAPOLIS, Oct. 8, 2020 /PRNewswire via COMTEX/ --
INDIANAPOLIS, Oct. 8, 2020 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) and Incyte (NASDAQ: INCY)...
Pune, Oct 08, 2020 (GLOBE NEWSWIRE via COMTEX) -- Global vitiligo treatment market is likely to gain impetus from an ever rising demand for innovative and...
Pune, Oct 08, 2020 (GLOBE NEWSWIRE via COMTEX) --
Pune, Oct. 08, 2020 (GLOBE NEWSWIRE) -- Global vitiligo treatment market is likely to gain impetus from an...
Oct 08, 2020 (The Expresswire) --
Global “Hodgkin's Lymphoma Treatment Market” report gives a historical overview of the Hodgkin's Lymphoma Treatment market...
